Citation 177680

THASTRUP,O: KNUDSEN,JB: LEMMICH,J: WINTHER,K:. (1985). INHIBITION OF HUMAN PLATELET AGGREGATION BY DIHYDROPYRANO AND DIHYDROFURANOCOUMARINS, A NEW CLASS OF CAMP-PHOSPHODIESTERASE INHIBITORS.. 34(12)

Citation Details

Title	INHIBITION OF HUMAN PLATELET AGGREGATION BY DIHYDROPYRANO AND DIHYDROFURANOCOUMARINS, A NEW CLASS OF CAMP-PHOSPHODIESTERASE INHIBITORS.
Authors	THASTRUP,O: KNUDSEN,JB: LEMMICH,J: WINTHER,K:
Year	1985
Volume	34
Issue	12

Summary

Year: 1985

Journal: Unknown

Organisms and Their Experiments (11)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	VISNADIN	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VISNADIN	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VISNADIN	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	VISNADIN	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VISNADIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	PTERYXIN	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERYXIN	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERYXIN	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	PTERYXIN	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERYXIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SAMIDIN,ISO:	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAMIDIN,ISO:	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAMIDIN,ISO:	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SAMIDIN,ISO:	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAMIDIN,ISO:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SAMIDIN	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAMIDIN	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAMIDIN	ACTIVE
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SAMIDIN	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAMIDIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	KHELLACTONE,CIS: DISENECIOYL:	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: DISENECIOYL:	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: DISENECIOYL:	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	KHELLACTONE,CIS: DISENECIOYL:	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: DISENECIOYL:	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	KHELLACTONE,CIS:	INACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS:	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS:	ACTIVE
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	KHELLACTONE,CIS:	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS:	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	PEUCEDANIN	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	PEUCEDANIN	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ATHAMANTIN	INACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHAMANTIN	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHAMANTIN	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ATHAMANTIN	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHAMANTIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ARCHANGELICIN	INACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARCHANGELICIN	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARCHANGELICIN	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ARCHANGELICIN	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARCHANGELICIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COLUMBIANADIN	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLUMBIANADIN	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLUMBIANADIN	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COLUMBIANADIN	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLUMBIANADIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	VAGINIDIOL	INACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VAGINIDIOL	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VAGINIDIOL	WEAK ACTIVITY
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	VAGINIDIOL	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VAGINIDIOL	ACTIVE

Show SPARQL Queries (1)